For Safer Pregnancies
Pre-eclampsia, a condition that occurs during pregnancy and is characterized by high-blood pressure, can lead to harmful or even fatal complications for both mother and child. Fortunately, our latest screening solutions allow pregnant women and their OBGYNs to identify a risk for this condition as early as the first trimester when treatment can be administered for better outcomes. In fact, a recent study showed that women who are identified as "at-risk" can reduce the rate of pre-eclampsia with a simple regimen of aspirin. In addition to our pre-eclampsia kits,we offer other technologies that aid in everything from fertility research to healthier pregnancies.
The largest prospective, randomized placebo controlled trial recently took place to study the prophylactic use of aspirin in women at increased risk of pre-eclampsia.
In recent years, prenatal screening for genetic disorders has become more commonly administered. But it has not been without its limitations. Thanks to collaborative research...
Every three minutes a new mother dies from postpartum hemorrhaging (PPH), the excessive loss of blood while giving birth. Fortunately, a research scientist in Australia is developing a new spray-dried oxytocin...
In all three trimesters best results are obtained by using the PlGF test result together with results for other markers, such as maternal history, ultrasound (uAD) and mean arterial blood pressure (MAP); the same combination of markers is suitable for use at every stage of pregnancy.
Our random access prenatal screening platform streamlines workflows in laboratories and clinics. Multiple samples can be processed at once and results are ready in 30 minutes. A full range of first- and second-trimester screening kits are available to support all of today's pre-natal screening strategies, from early identification of pre-eclampsia to screening for aneuploidies.
Innovation in Pre-eclampsia Research - ASPRE Trial Results
Kypros Nicolaides, Professor of Fetal Medicine, King’s College, London has carried out extensive research in fetal diagnosis and therapy, leading to the publication of more than 1,200 peer-reviewed papers in scientific journals. He has provided training in Fetal Medicine to more than 500 doctors from 50 countries and has encouraged many more young doctors to undertake research in the field. In 1995, he founded the Fetal Medicine Foundation, which has donated more than £15 million to promote research and training in Fetal Medicine throughout the World.Learn more about the ASPRE Trial